An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy
Clinical trial NCT03917719 · TERMINATED
Trial details
- NCT number
- NCT03917719
- Sponsor
- Catabasis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-14
- Primary completion
- 2020-10-26
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.